List of Tables
Table 1. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Market Competitive Situation by Manufacturers in 2025
Table 4. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Medications for Chronic Rhinosinusitis With Nasal Polyps Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Medications for Chronic Rhinosinusitis With Nasal Polyps, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Medications for Chronic Rhinosinusitis With Nasal Polyps, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Medications for Chronic Rhinosinusitis With Nasal Polyps, Product Types and Applications
Table 12. Global Key Manufacturers of Medications for Chronic Rhinosinusitis With Nasal Polyps, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Companies by Tier (Tier 1, Tier 2, Tier 3), based on Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Region (K Units), 2021–2026
Table 18. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Region (2021–2026)
Table 19. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Region (K Units), 2027–2032
Table 20. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Region (2027–2032)
Table 21. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Region (US$ Million), 2021–2026
Table 22. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Market Share by Region (2021–2026)
Table 23. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Region (US$ Million), 2027–2032
Table 24. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Market Share by Region (2027–2032)
Table 25. North America Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Country (K Units), 2021–2026
Table 27. North America Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Country (K Units), 2027–2032
Table 28. North America Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country (US$ Million), 2021–2026
Table 29. North America Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Country (K Units), 2021–2026
Table 32. Europe Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Country (K Units), 2027–2032
Table 33. Europe Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Country (K Units), 2021–2026
Table 42. Latin America Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Country (K Units), 2027–2032
Table 43. Latin America Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Medications for Chronic Rhinosinusitis With Nasal Polyps Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue by Country (US$ Million), 2027–2032
Table 50. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units) by Type (2021–2026)
Table 51. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units) by Type (2027–2032)
Table 52. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Type (2021–2026)
Table 53. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Type (2027–2032)
Table 54. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Market Share by Type (2021–2026)
Table 57. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Market Share by Type (2027–2032)
Table 58. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Price (US$/Unit) by Type (2021–2026)
Table 59. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Price (US$/Unit) by Type (2027–2032)
Table 60. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units) by Application (2021–2026)
Table 61. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units) by Application (2027–2032)
Table 62. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Application (2021–2026)
Table 63. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Application (2027–2032)
Table 64. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Market Share by Application (2021–2026)
Table 67. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Market Share by Application (2027–2032)
Table 68. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Price (US$/Unit) by Application (2021–2026)
Table 69. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Price (US$/Unit) by Application (2027–2032)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Sanofi Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Regeneron Company Information
Table 76. Regeneron Description and Business Overview
Table 77. Regeneron Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Regeneron Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 79. Regeneron Recent Developments/Updates
Table 80. GSK Company Information
Table 81. GSK Description and Business Overview
Table 82. GSK Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. GSK Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 84. GSK Recent Developments/Updates
Table 85. Genentech Company Information
Table 86. Genentech Description and Business Overview
Table 87. Genentech Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Genentech Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 89. Genentech Recent Developments/Updates
Table 90. Novartis Company Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Novartis Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 94. Novartis Recent Developments/Updates
Table 95. Optinose Company Information
Table 96. Optinose Description and Business Overview
Table 97. Optinose Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Optinose Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 99. Optinose Recent Developments/Updates
Table 100. AstraZeneca Company Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AstraZeneca Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. Teva Company Information
Table 106. Teva Description and Business Overview
Table 107. Teva Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Teva Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 109. Teva Recent Developments/Updates
Table 110. West-Ward Pharmaceuticals Company Information
Table 111. West-Ward Pharmaceuticals Description and Business Overview
Table 112. West-Ward Pharmaceuticals Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. West-Ward Pharmaceuticals Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 114. West-Ward Pharmaceuticals Recent Developments/Updates
Table 115. Apotex Corp. Company Information
Table 116. Apotex Corp. Description and Business Overview
Table 117. Apotex Corp. Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Apotex Corp. Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 119. Apotex Corp. Recent Developments/Updates
Table 120. Akorn Company Information
Table 121. Akorn Description and Business Overview
Table 122. Akorn Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Akorn Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 124. Akorn Recent Developments/Updates
Table 125. Wockhardt Company Information
Table 126. Wockhardt Description and Business Overview
Table 127. Wockhardt Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Wockhardt Medications for Chronic Rhinosinusitis With Nasal Polyps Product
Table 129. Wockhardt Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Medications for Chronic Rhinosinusitis With Nasal Polyps Distributors List
Table 133. Medications for Chronic Rhinosinusitis With Nasal Polyps Customers List
Table 134. Medications for Chronic Rhinosinusitis With Nasal Polyps Market Trends
Table 135. Medications for Chronic Rhinosinusitis With Nasal Polyps Market Drivers
Table 136. Medications for Chronic Rhinosinusitis With Nasal Polyps Market Challenges
Table 137. Medications for Chronic Rhinosinusitis With Nasal Polyps Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Medications for Chronic Rhinosinusitis With Nasal Polyps
Figure 2. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Market Share by Type: 2025 & 2032
Figure 4. Glucocorticoids Product Picture
Figure 5. Biologics Product Picture
Figure 6. Antihistamines Product Picture
Figure 7. Anti-leukotriene drugs Product Picture
Figure 8. Other Product Picture
Figure 9. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Market Share by Application: 2025 & 2032
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Other
Figure 14. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Market Size (US$ Million), 2021–2032
Figure 16. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Sales (K Units), 2021–2032
Figure 17. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Average Price (US$/Unit), 2021–2032
Figure 18. Medications for Chronic Rhinosinusitis With Nasal Polyps Report Years Considered
Figure 19. Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Share by Manufacturers in 2025
Figure 20. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Medications for Chronic Rhinosinusitis With Nasal Polyps Players: Market Share by Revenue in Medications for Chronic Rhinosinusitis With Nasal Polyps in 2025
Figure 22. Medications for Chronic Rhinosinusitis With Nasal Polyps Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Country (2021–2032)
Figure 25. North America Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Market Share by Country (2021–2032)
Figure 26. United States Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Country (2021–2032)
Figure 29. Europe Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Market Share by Country (2021–2032)
Figure 30. Germany Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Market Share by Region (2021–2032)
Figure 37. China Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Country (2021–2032)
Figure 45. Latin America Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Medications for Chronic Rhinosinusitis With Nasal Polyps Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Medications for Chronic Rhinosinusitis With Nasal Polyps Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Medications for Chronic Rhinosinusitis With Nasal Polyps by Type (2021–2032)
Figure 56. Global Revenue Market Share of Medications for Chronic Rhinosinusitis With Nasal Polyps by Type (2021–2032)
Figure 57. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Medications for Chronic Rhinosinusitis With Nasal Polyps by Application (2021–2032)
Figure 59. Global Revenue Market Share of Medications for Chronic Rhinosinusitis With Nasal Polyps by Application (2021–2032)
Figure 60. Global Medications for Chronic Rhinosinusitis With Nasal Polyps Price (US$/Unit) by Application (2021–2032)
Figure 61. Medications for Chronic Rhinosinusitis With Nasal Polyps Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
